Lisa A Orloff1, Julia E Noel1, Brendan C Stack2, Marika D Russell3, Peter Angelos4, Jung Hwan Baek5, Kevin T Brumund6, Feng-Yu Chiang7, Mary Beth Cunnane8, Louise Davies9, Andrea Frasoldati10, Anne Y Feng11, Laszlo Hegedüs12, Ayaka J Iwata13, Emad Kandil14, Jennifer Kuo15, Celestino Lombardi16, Mark Lupo17, Ana Luiza Maia18, Bryan McIver19, Dong Gyu Na20, Roberto Novizio21, Enrico Papini22, Kepal N Patel23, Leonardo Rangel24, Jonathon O Russell25, Jennifer Shin11, Maisie Shindo26, David C Shonka27, Amanda S Karcioglu28,29, Catherine Sinclair30, Michael Singer31, Stefano Spiezia32, Jose Higino Steck33, David Steward34, Kyung Tae35, Neil Tolley36, Roberto Valcavi21, Ralph P Tufano25, R Michael Tuttle37, Erivelto Volpi38, Che Wei Wu39, Amr H Abdelhamid Ahmed40, Gregory W Randolph40. 1. Department of Otolaryngology - Head & Neck Surgery, Stanford University School of Medicine, Stanford, California, USA. 2. Department of Otolaryngology - Head & Neck Surgery, Southern Illinois University School of Medicine, Springfield, Illinois, USA. 3. Department of Otolaryngology - Head & Neck Surgery, San Francisco School of Medicine, University of California, San Francisco, California, USA. 4. Department of Surgery, University of Chicago, Chicago, Illinois, USA. 5. Department of Radiology, Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. 6. Division of Otolaryngology - Head and Neck Surgery, Department of Surgery, University of California, San Diego, San Diego, California, USA. 7. Department of Otolaryngology - Head and Neck Surgery, E-Da Hospital, School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan. 8. Department of Radiology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA. 9. The Section of Otolaryngology, The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. 10. Department of Endocrinology and Metabolism, Arcispedale Santa Maria Nuova IRCCS-ASL, Reggio Emilia, Italy. 11. Department of Otolaryngology - Head and Neck Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. 12. Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark. 13. Department of Otolaryngology - Head & Neck Surgery, Kaiser Permanente, Santa Clara, California, USA. 14. Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA. 15. Department of Surgery, Columbia University Irving Medical Center, New York, New York, USA. 16. Division of Endocrine and Metabolic Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. 17. Thyroid & Endocrine Center of Florida, Sarasota, Florida, USA. 18. Unidade de Tireoide, Hospital de Clínicas de Porto Alegre, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. 19. Department of Head and Neck-Endocrine Oncology, H. Lee Moffitt Cancer Center, Research Institute, Tampa, Florida, USA. 20. Department of Radiology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, South Korea. 21. Endocrine & Thyroid Clinic (E.T.C.), Reggio Emilia, Italy. 22. Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Rome, Italy. 23. Department of Surgery, New York University, New York, New York, USA. 24. Division of Otorhinolaryngology - Head and Neck Surgery, State University of Rio de Janeiro, Rio de Janiero, Brazil. 25. Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 26. Department of Otolaryngology - Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon, USA. 27. Department of Otolaryngology - Head and Neck Surgery, University of Virginia Health System, Charlottesville, Virginia, USA. 28. Division of Otolaryngology - Head and Neck Surgery, Department of Surgery, NorthShore University Health System, Evanston, Illinois, USA. 29. Clinician Educator, Pritzker School of Medicine, Chicago, Illinois, USA. 30. Department of Otolaryngology - Head and Neck Surgery, Mount Sinai West Hospital, New York, New York, USA. 31. Department of Otolaryngology - Head and Neck Surgery, Henry Ford Health System, Detroit, Michigan, USA. 32. Endocrine Surgery, Ospedale del Mare, ASL NA1 Centro, Naples, Italy. 33. Department of Otorhinolaryngology - Head and Neck Surgery, University of Campinas, Campinas, Brazil. 34. Department of Otolaryngology - Head and Neck Surgery, University of Cincinnati, Cincinnati, Ohio, USA. 35. Department of Otolaryngology - Head and Neck Surgery, College of Medicine, Hanyang University, Seoul, South Korea. 36. Hammersmith Hospital, Imperial College NHS Healthcare Trust, London, UK. 37. Endocrine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 38. Oncology Center, Oswaldo Cruz German Hospital, Sao Paulo, Brazil. 39. Department of Otolaryngology - Head and Neck Surgery, Kaohsiung Medical University Hospital, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. 40. Department of Otolaryngology - Head and Neck Surgery, Division of Thyroid and Parathyroid Endocrine Surgery, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
BACKGROUND: The use of ultrasound-guided ablation procedures to treat both benign and malignant thyroid conditions is gaining increasing interest. This document has been developed as an international interdisciplinary evidence-based statement with a primary focus on radiofrequency ablation and is intended to serve as a manual for best practice application of ablation technologies. METHODS: A comprehensive literature review was conducted to guide statement development and generation of best practice recommendations. Modified Delphi method was applied to assess whether statements met consensus among the entire author panel. RESULTS: A review of the current state of ultrasound-guided ablation procedures for the treatment of benign and malignant thyroid conditions is presented. Eighteen best practice recommendations in topic areas of preprocedural evaluation, technique, postprocedural management, efficacy, potential complications, and implementation are provided. CONCLUSIONS: As ultrasound-guided ablation procedures are increasingly utilized in benign and malignant thyroid disease, evidence-based and thoughtful application of best practices is warranted.
BACKGROUND: The use of ultrasound-guided ablation procedures to treat both benign and malignant thyroid conditions is gaining increasing interest. This document has been developed as an international interdisciplinary evidence-based statement with a primary focus on radiofrequency ablation and is intended to serve as a manual for best practice application of ablation technologies. METHODS: A comprehensive literature review was conducted to guide statement development and generation of best practice recommendations. Modified Delphi method was applied to assess whether statements met consensus among the entire author panel. RESULTS: A review of the current state of ultrasound-guided ablation procedures for the treatment of benign and malignant thyroid conditions is presented. Eighteen best practice recommendations in topic areas of preprocedural evaluation, technique, postprocedural management, efficacy, potential complications, and implementation are provided. CONCLUSIONS: As ultrasound-guided ablation procedures are increasingly utilized in benign and malignant thyroid disease, evidence-based and thoughtful application of best practices is warranted.